Ethylisopropyltryptamine
| Clinical data | |
|---|---|
| Other names | EiPT; N-Ethyl-N-isopropyltryptamine |
| Routes of administration | Oral[1] |
| Drug class | Psychedelic drug; Serotonergic psychedelic |
| ATC code |
|
| Legal status | |
| Legal status | |
| Pharmacokinetic data | |
| Duration of action | 4–6 hours[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H22N2 |
| Molar mass | 230.355 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 71 to 73 °C (160 to 163 °F) |
| |
| |
| (verify) | |
Ethylisopropyltryptamine (EiPT), also known as N-ethyl-N-isopropyltryptamine, is a psychedelic drug of the tryptamine family.[1] It is taken orally.[1]
EiPT appears to have been first synthesized and described by Alexander Shulgin[1] following the Speeter-Anthony route.[2][3][4]
Use and effects
[edit]In his book TiHKAL (Tryptamines I Have Known and Loved), Alexander Shulgin lists the dose of EiPT as 24 to 40 mg and its duration as 4 to 6 hours.[1] According to Shulgin, this compound tends to produce nausea, dysphoria, and other unpleasant side effects.[1] It also seems to largely lack the hallucinatory and visual properties usually associated with psychedelic drugs.[1]
Interactions
[edit]Chemistry
[edit]EiPT is short for N-ethyl-N-isopropyltryptamine.[1] The full chemical name of this structure is N-ethyl-N-[2-(1H-indol-3-yl)ethyl]propan-2-amine. The compound is a substituted tryptamine, which all belong to a larger family of compounds known as indolethylamines.[1]
Synthesis
[edit]The chemical synthesis of EiPT has been described.[1]
Analogues
[edit]Analogues of EiPT include 4-HO-EiPT, 4-AcO-EiPT, 5-MeO-EiPT, methylisopropyltryptamine (MiPT), propylisopropyltryptamine (PiPT), ethylpropyltryptamine (EPT), diethyltryptamine (DET), and diisopropyltryptamine (DiPT), among others.[1]
Society and culture
[edit]Legal status
[edit]United States
[edit]EiPT is unscheduled and uncontrolled in the United States, but possession and sales of EiPT could be prosecuted under the Federal Analog Act because of its structural similarities to DET.[citation needed]
See also
[edit]References
[edit]- 1 2 3 4 5 6 7 8 9 10 11 12 Shulgin A, Shulgin A (September 1997). TiHKAL: The Continuation. Berkeley, California: Transform Press. ISBN 0-9630096-9-9. OCLC 38503252. "#10. EIPT".
- ↑ Speeter ME, Anthony WC (December 1954). "The action of oxalyl chloride on indoles: A new approach to tryptamines". Journal of the American Chemical Society. 76 (23): 6208–6210. doi:10.1021/ja01652a113.
- ↑ Brandt SD, Freeman S, Fleet IA, McGagh P, Alder JF (November 2004). "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS". The Analyst. 129 (11): 1047–57. doi:10.1039/b407239c. PMID 15508033.
- ↑ Brandt SD, Freeman S, Fleet IA, McGagh P, Alder JF (March 2005). "Analytical chemistry of synthetic routes to psychoactive tryptamines. Part II. Characterisation of the Speeter and Anthony synthetic route to N,N-dialkylated tryptamines using GC-EI-ITMS, ESI-TQ-MS-MS and NMR". The Analyst. 130 (3): 330–44. doi:10.1039/b413014f. PMID 15724162.